Dr. Kolansky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Civic Center Blvd
Philadelphia, PA 19104- Is this information wrong?
Summary
- Dr. Daniel Kolansky is an interventional cardiologist in Philadelphia, PA at the Hospital of the University of Pennsylvania. He received his medical degree from Yale University School of Medicine and has been in practice 33 years. He specializes in interventional cardiology and general cardiology. He is currently the Associate Chief for Clinical Affairs in the Cardiovascular Division at the Hospital of the University of Pennsylvania where he serves as Professor of Medicine, and is also the Director of the Cardiac Care Unit at the Hospital.
Education & Training
- Yale-New Haven Medical CenterFellowship, Cardiovascular Disease, 1987 - 1992
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1987
- Yale School of MedicineClass of 1984
Certifications & Licensure
- FL State Medical License 1995 - 2026
- PA State Medical License 1992 - 2024
- CT State Medical License 1986 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow Society for Coronary Angiography& Intervention (SCAI)
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Philadelphia Magazine Castle Connolly, 2010
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsIncrease in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure.J David Smeijer, Jeroen Koomen, Donald E Kohan, John J V McMurray, George L Bakris, Ricardo Correa-Rotter, Fan-Fan Hou, James L Januzzi, Dalane W Kitzman, Daniel M Kol...> ;JACC. Heart Failure. 2022 Jul 1
- 2 citationsAttitudes toward pharmacogenetics in patients undergoingtesting following percutaneous coronary intervention.Grace Lee, Lisa A Varughese, Laura Conway, Carol Stojinski, Sandhya Ashokkumar, Karen Monono, William Matthai, Daniel M Kolansky, Jay Giri, Sony Tuteja> ;Personalized Medicine. 2022 Mar 1
- Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions.Glenda Hoffecker, Genevieve P Kanter, Yao Xu, William Matthai, Daniel M Kolansky, Jay Giri, Sony Tuteja> ;Personalized Medicine. 2022 Jan 1
- Join now to see all
Journal Articles
- Performance of Hospitals When Assessing Disease-Based Mortality Compared with Procedural Mortality for Patients with Acute Myocardial InfarctionAshwin S Nathan, Rishi K Wadhera, Deepak L Bhatt, Daniel M Kolansky, Ajay J Kirtane, Robert W Yeh, Tracy Y Wang, Jay Giri, JAMA Cardiology
- Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016Daniel M Kolansky, Taisei Kobayashi, Peter W Groeneveld, Jay Giri, JAMA
Other
- Possible role of long-term medical therapies to prevent restenosis following percutaneous coronary interventionKolansky DM, Klugherz BD
http://www.uptodate.com/contents/possible-role-of-long-term-medical-therapies-to-prevent-restenosis-
UpToDate, Wolters Kluwer Health - 2012-03-01 - Use of intracoronary radiation to prevent restenosisKolansky DM, Klugherz BD
http://www.uptodate.com/contents/use-of-intracoronary-radiation-to-prevent-restenosis
UpToDate, Wolters Kluwer Health - 2012-04-18
Authored Content
- SCAI Expert Consensus Update on Best Practices in the Cardiac Catheterization Laboratory: Optimizing Quality of CareJuly 2021
- Performance of Hospitals When Assessing Disease-Based Mortality Compared with Procedural Mortality for Patients with Acute Myocardial InfarctionMay 2020
Press Mentions
- What Is Arteriosclerosis and How Do I Prevent It?August 1st, 2022
- Safety of Intravenous Cangrelor Administration for Antiplatelet Bridging in Hospitalized Patients: A Retrospective StudyNovember 30th, 2021
- Flip the Script: Cardiac Rehabilitation Is Underused, but a Simple Change Could Fix ThatJanuary 14th, 2021
- Join now to see all
Grant Support
- Analysis Of Na,K-Atpase Isoforms Expressed In The HeartNational Heart, Lung, And Blood Institute1989
Professional Memberships
- Fellow
- Member
- Society for Angiography & Intervention (SCAI)Fellow
Hospital Affiliations
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
- Penn Presbyterian Medical CenterPhiladelphia, Pennsylvania
- Philadelphia Veterans Affairs Medical CenterPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: